Table 3.
Imaging | Finding | Prevalence (%) | Precision (95 % CI) | Recall (95 % CI) | F-measure |
---|---|---|---|---|---|
Screening mammography n = 197 | Positive BI-RADSa | 16/197 | 1.0 | 1.0 (0.8, 1.0) | 1.0 |
(8.1) | (0.8, 1.0) | ||||
Calcification | 16/197 | 0.93 | 0.9 | 0.9 | |
(8.1) | (0.7, 1.0) | (0.6, 1.0) | |||
Mass | 9/197 | 1.0 | 0.7 | 0.8 | |
(4.6) | (0.5, 1.0) | (0.3, 0.9) | |||
Implants | 1/197 | 0.50 | 1.0 | 0.7 | |
(0.5) | (0.0, 1.0) | (0.0, 1.0) | |||
Architectural distortion | 0/197 | – | – | – | |
(0.0) | |||||
Asymmetry | 7/196 | 0.9 | 1.0 | 0.9 | |
(3.6) | (0.5, 1.0) | (0.6, 1.0) | |||
Diagnostic mammography n = 200 | Positive BI-RADSa | 75/198 | 1.0 | 1.0 | 1.0 |
(37.9) | (0.9, 1.0) | (0.9, 1.0) | |||
Calcification | 64/200 | 1.0 | 1.0 | 1.0 | |
(32.0) | (0.9, 1.0) | (0.9, 1.0) | |||
Mass | 49/200 | 0.9 | 0.9 | 0.9 | |
(24.5) | (0.8, 1.0) | (0.8, 1.0) | |||
Implants | 7/200 | 1.0 | 1.0 | 1.0 | |
(3.5) | (0.6, 1.0) | (0.6, 1.0) | |||
Architectural distortion | 18/200 | 0.9 | 0.9 | 0.9 | |
(9.0) | (0.6, 1.0) | (0.6, 1.0) | |||
Asymmetry | 25/200 | 0.6 | 0.8 | 0.7 | |
(12.5) | (0.4, 0.8) | (0.6, 0.9) | |||
Digital tomosynthesis n = 200 | Positive BI-RADSa | 24/200 | 1.0 | 1.0 | 1.0 |
(12.0) | (0.9, 1.0) | (0.9, 1.0) | |||
Calcification | 16/200 | 0.9 | 0.9 | 0.9 | |
(8.0) | (0.6, 1.0) | (0.7, 1.0) | |||
Mass | 30/200 | 1.0 | 1.0 | 1.0 | |
(15.0) | (0.8, 1.0) | (0 .8, 1.0) | |||
Implants | 3/200 | 1.0 | 1.0 | 1.0 | |
(1.5) | (0.3, 1.0) | (0.3, 1.0) | |||
Architectural distortion | 11/200 | 0.8 | 0.8 | 0.8 | |
(5.5) | (0.5,1.0) | (0.5, 1.0) | |||
Asymmetry | 10/200 | 0.6 | 1.0 | 0.8 | |
(5.0) | (0.4, 0.8) | (0.7, 1.0) | |||
Breast magnetic resonance imaging n = 145 | Positive BI-RADSa | 31/132 | 1.0 | 0.9 | 1.0 |
(23.5) | (0.9, 1.0) | (0.8, 1.0) | |||
Mass | 35/141 | 0.9 | 0.9 | 0.9 | |
(24.8) | (0.7, 1.0) | (0.7, 1.0) | |||
Cysts | 31/141 | 0.9 | 1.0 | 0.9 | |
(22.0) | (0.7, 1.0) | (0.9, 1.0) | |||
Implants | 12/141 | 0.9 | 1.0 | 1.0 | |
(8.5) | (0.6, 1.0) | (0.7, 1.0) | |||
NME | 18/141 | 0.8 | 1.0 | 0.9 | |
(12.8) | (0.6, 0.9) | (0.8, 1.0) | |||
Focus | 29/141 | 0.9 | 1.0 | 1.0 | |
(20.6) | (0.8, 1.0) | (0.9, 1.0) | |||
Breast ultrasound n = 199 | Positive BI-RADSa | 69/197 | 1.0 | 1.0 | 1.0 |
(35.0) | (0.9, 1.0) | (0.9, 1.0) | |||
Mass | 50/198 | 0.8 | 1.0 | 0.9 | |
(25.3) | (0.6, 0.8) | (0.9, 1.0) | |||
Cysts | 49/199 | 0.9 | 0.9 | 0.9 | |
(24.6) | (0.8, 1.0) | (0.8, 1.0) | |||
Architectural distortion | 0/199 | – | – | – | |
(0.0) |
aA positive final assessment is defined as BI-RADS categories 0, 3, 4, or 5 on screening mammogram and BI-RADS categories 4 or 5 on diagnostic workup